Truveta Research

Defining what’s possible and demonstrating the potential of Truveta

Truveta Research is a highly accomplished team of physician scientists, epidemiologists, applied scientists, and data analysts. Their focus is showcasing the possibilities of Truveta to empower researchers to study patient care and outcomes.   

The team focuses on studies that explore health equity, monitor public health, and emulate randomized clinical trials with real-world data to improve health outcomes. 

Research in action

Truveta Research recently used Truveta Studio to explore potential racial and ethnic disparities in COVID hospitalizations during different time periods throughout the pandemic.

Featured research insight

Disparities in COVID-19 Hospitalizations: From Insights to Publication

Many researchers have goals to conduct novel science, uncover new trends, report findings that increase knowledge on a given topic, and push the field forward. To accomplish…

Publications & resources

Truveta Research publications

Respiratory Syncytial Virus (RSV) Hospitalization Trends

This report contains current hospitalization trends associated with respiratory syncytial virus (RSV). We used a subset of Truveta Data to identify laboratory-confirmed RSV infections in children and adults. This report is intended to describe trends and comparisons of RSV-associated hospitalizations in different demographic groups and across seasons.

Read the report

Download the supplemental materials

COVID Treatment and In-hospital Length of Stay Inequalities Between Race in the US Over Time

Demonstrated health inequalities persist in the United States. SARS-CoV-2 (COVID) has been no exception, with access to treatment and hospitalization differing across race or ethnic group. Here we aim to assess differences in treatment with remdesivir and hospital length of stay across four waves of the pandemic.

Read more on Frontiers

Risk of COVID-19 Breakthrough Infection and Hospitalization in Individuals with Comorbidities

Studies have shown that those with certain high-risk comorbidities such as diabetes, chronic kidney disease (CKD), chronic lung disease, or those with immunocompromising conditions have increased risk of hospitalization from COVID-19. Here we estimate the elevated risks of breakthrough infection and hospitalization in fully vaccinated individuals with comorbidities.

Read more

Selected eBooks & one-pagers

eBook: COVID-19 Insights

The Truveta Research team spent almost a year digging into the data to inform insights and studies to better understand health across our de-identified population with a focus on those affected by COVID-19 and the effects of the pandemic. 

Read more

eBook: Peripheral Artery Disease Treatment and Outcomes

Peripheral Artery Disease (PAD) is a common disease that causes the narrowing of the arteries in the extremities. As part of PAD Awareness month, Truveta Research investigated disparities in the frequency of common procedures used to treat PAD, known as endovascular (or minimally invasive) revascularization, and the associated outcomes.

Read more

One-Pager: Long COVID & Mental Health

Some diagnosed with COVID-19 have a variety of post-COVID-19 symptoms, commonly referred to as long COVID-19. Given the potential dire outcomes from mental health disorders, it is important to understand mental health outcomes as the effects of long COVID-19 are becoming apparent.​

Read more

One-Pager: Who is Getting Long COVID

The risk factors for developing long COVID-19 are still being studied in the United States and worldwide. We conducted independent research using a subset of Truveta data to learn more long COVID-19. 

Read more

One-Pager: Disparities in COVID-19 Hospitalizations

COVID-19 impacted communities disproportionately. Especially in the early days of the pandemic, countless reports of inequitable access to treatments and treatment pathways brought to light existing and new disparities in health outcomes.

Read more